BIO statement on new list of medicines targeted for Government price setting

BIO

17 January 2025 - The Biotechnology Innovation Organization (BIO) today released the following statement after the Biden administration released a list of 15 medicines being selected for government price setting:

“In the final hours of this administration, President Biden is doubling down on a flawed drug pricing scheme that is jeopardising seniors’ access to important medicines and undermining the development of new cures and treatments.

Read BIO Statement

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing